Physician profile
Jonathan A Praeger
NPI 1083927503
$60,201.95
in general payments reported to CMS, 2019-2025
10 companies · $3,676 in 2025
The $3,676 reported for 2025 was more than what 78% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $717 · 2020: $726 · 2021: $3,469 · 2022: $2,914 · 2023: $4,160 · 2024: $45K · 2025: $3,676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $28K · Food and Beverage: $10K · Honoraria: $7,200 · Travel and Lodging: $7,146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $27,900.00 |
| Food and Beverage | $10,129.92 |
| Honoraria | $7,200.00 |
| Travel and Lodging | $7,146.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $38,258.92 | 2020-2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax, Atricure Cryoice Cryoablation System (Cryo2) |
| Abiomed | $12,105.33 | 2021-2025 | Impella |
| Edwards Lifesciences Corporation | $5,253.01 | 2019-2025 | Mitris Resilia Mitral Valve, Carpentier-Edwards Physio II Annuloplasty Ring, Inspiris Resilia Aortic Valve |
| Abbott Laboratories | $3,724.65 | 2019-2025 | 2nd Gen Centrimag Primary Console, Allure Quadra, Thoratec Heartmate 3 Lvas Implant Kit |
| Intuitive Surgical, INC. | $403.54 | 2019 | |
| Artivion, INC. | $219.04 | 2023-2025 | Amds-Ascyrus Medical, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Bioglue Surgical Adhesive |
| Ethicon US, LLC | $115.16 | 2024-2025 | Surgiflo Hemostatic Matrix |
| Baxter Healthcare | $51.94 | 2023 | Floseal |
| Medtronic, INC. | $48.97 | 2024 | Penditure |
| Genzyme Corporation | $21.39 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Praeger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.